CELL INTELLIGENCE · 肿瘤细胞治疗研究

中枢神经系统肿瘤中的神经炎症

Neuroinflammation in Central Nervous System Tumors.

将免疫肽组学与液体活检相结合用于精准肿瘤学

Integrating immunopeptidomics with liquid biopsy for precision oncology.

移植后淋巴增殖性疾病中的免疫抑制性肿瘤微环境：发病机制与新型治疗前沿

The immunosuppressive tumor microenvironment in post-transplant lymphoproliferative disorder: pathogenesis and novel therapeutic frontiers.

黑色素瘤治疗的演变：从历史视角到未来方向

The Emerging Melanoma Management: Historical Perspective to Future Directions.

来自 IL-18 过表达和/或 TGF-β1 缺失肿瘤细胞的细胞外囊泡作为下一代 DC 疫苗的免疫原性抗原来源

Extracellular vesicles from IL-18-overexpressing and/or TGF-β1-deprived tumor cells as an immunogenic antigen source for next-generation DC vaccines.

缺氧促进 BCMA 丢失与抑制性分泌组从而阻碍多发性骨髓瘤的 CAR-T 细胞治疗

Hypoxia promotes BCMA loss and a suppressive secretome thereby hindering CAR T cell therapy in multiple myeloma.

本研究表明，缺氧会降低 BCMA 表达并增强包括 sEVs 在内的免疫抑制因子的分泌，从而限制 BCMA CAR-T 细胞疗法在多发性骨髓瘤中的疗效。

从 CAR-T 细胞到外泌体免疫治疗：探索无细胞靶向肿瘤治疗的前沿

From CAR-T Cells to Exosome-Based Immunotherapy: Exploring the Frontiers of Cell-Free Targeted Cancer Therapeutics.

通过嵌合抗原受体协调肿瘤抗原摄取与树突状细胞活化

Coordinate tumor-antigen uptake and dendritic cell activation by chimeric antigen receptors.

细胞驱动的外泌体内包裹叶绿酸基碳点用于增强光动力治疗：miRNA 谱分析揭示机制见解

Cell-Driven Encapsulation of Chlorophyllin-Based Carbon Dots within Exosomes for Enhanced Photodynamic Therapy: miRNA Profiling Reveals Mechanistic In

CAR-T 免疫疗法与新兴技术的交叉

The intersection of CAR-T immunotherapy with emerging technologies.